Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine
Department of Anesthesia and Perioperative Care, University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, Room 3C-38, 1001 Potrero Avenue, San Francisco, CA 94110, USA
Authors to whom correspondence should be addressed.
Received: 20 November 2018 / Accepted: 22 November 2018 / Published: 26 November 2018
Note: In lieu of an abstract, this is an excerpt from the first page.
Botulism, caused by exposure to one or more of the eight serotypes of botulinum neurotoxins (BoNTs) (BoNT/A through H), is often fatal without rapid treatment. [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Lou, J.; Marks, J.D. Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine. Toxins 2018, 10, 495.
Lou J, Marks JD. Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine. Toxins. 2018; 10(12):495.
Lou, Jianlong; Marks, James D. 2018. "Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine." Toxins 10, no. 12: 495.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.